Tel

13644

Selected Publications

1.Tsai WC, Hueng DY, Lin CK. Nuclear overexpression of urocortin discriminates primary brain tumors from reactive gliosis. APMIS. 2015;123:465-472.
2.Cheng MF, Tsai WC, Hsia KT, Yang YS, Jin JS. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia. APMIS. 2014; 122:147-154.
3.Cheng MF, Tsai WC, Lin YC, Hsia KT, Jin JS. The Association of Urocortin Expression with Clinicopathologic Parameters of Gastric Adenocarcinomas. Appl Immunohistochem Mol Morphol. 2014; 22:288-94.
4.Tsai WC, Chen Y, Huang LC, Lee HS, Ma HI, Huang SM, Sytwu HK, Hueng DY. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas. J Neurooncol. 2013;114:281–290.
5.Tsai WC, Lee HS, Lin CK, Chen A, Nieh S, Ma HI. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas. Histopathology. 2012;61(5):844-856.
6.Tsai WC, Lin CK, Lee HS, Gao HW, Nieh S, Chan DC, Jin JS. The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma. APMIS. 2013;121(3):171-181.
7.Tsai WC, Lin CK, Yang YS, Chan DC, Gao HW, Chang FN, Jin JS. The Correlations of LMX1A and Osteopontin Expression to the Clinicopathologic Stages in Pancreatic Adenocarcinoma. Appl Immunohistochem Mol Morphol. 2013;21(5):395-400.
8.Tsai WC, Lin CK, Lee HS, Chen A, Nieh S, Yu CP, Wu CC, Jao SW, Jin JS. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan. Chin J Physiol. 2012;55:352-360.
9.Tsai WC, Lee HS, Jin JS, Gao HW, Chao TK, Chen A, Nieh S, Chan DC, Chang FN, Lin CK. Association between Osteopontin and EGFR Expression with Clinicopathological Parameters in Hepatocellular Carcinoma. Chin J Physiol. 2012;55:412-420.
10. Tsai WC, Chao YC, Lee WH, Chen A, Sheu LF, Jin JS. Increasing EMMPRIN and matriptase expression hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters. Histopathology. 2006;49(4):388-395.
11. Tsai WC, Chao YC, Sheu LF, Chang JL, Nieh S, Jin JS. Overexpression of fascin-1 in advanced colorectal adenocarcinoma: Tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers. 2007; 23(3):153-60.
12. Tsai WC, Chu CH, Yu CP, Sheu LF, Chen A, Chiang H, Jin JS. Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women: Tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers. 2008; 24:89-99.
13. Tsai WC, Jin JS, Chang WK, Chan DC, Yeh MK, Cherng SC, Lin LF, Sheu LF, Chao YC. Association of cortactin and fascin-1 expression in gastric adenocarcinoma: Correlation with clinicopathological parameters. J Histochem Cytochem. 2007;55(9):955-62.
14. Tsai WC, Chao YC, Sheu LF, Lin YF, Nieh S, Chen A, Yu CP, Jin JS. EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people. APMIS. 2007;115(8):929-38.
15. Tsai WC, Sheu LF, Nieh S, Yu CP, Sun GH, Lin YF, Chen A, Jin JS. Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters.. World J Urol. 2007;25(1):73-80.
16. Tsai WC, Jin JS, Yu JC, Sheu LF. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system. Int J Surg Pathol. 2006;14(2):127-31
17. Tsai WC, Sheu LF, Chao YC, Chen A, Chiang H, Jin JS. Decreased matriptase /HAI-1 ratio in advanced colorectal adenocacinoma of Chinese patients. Chinese J Physiol. 2007;50(5):225-231